LMD-15. Beyond cytologY - A single institution experience using CNSide(TM) for diagnosing and monitoring treatment response in Non-Small Cell Lung Cancer patients with Leptomeningeal Carcinomatosis (LMC)

INTRODUCTION: Leptomeningeal Carcinomatosis (LMC) occurs in 3–9% of Non-Small Cell Lung Cancer (NSCLC) patients. Diagnosis of LMC includes clinical evaluation, imaging, and cytology. These have modest sensitivity and are inadequate for monitoring treatment response. Biocept’s CNSide(TM) is a proprie...

Descripción completa

Detalles Bibliográficos
Autores principales: Akerley, Wallace, Puri, Sonam, Chalmers, Anna, Blouw, Barbara, Boorgula, Smitha, Schultz, Robbie, Fisher, Deanna, Dugan, Michael, Mayer, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351243/
http://dx.doi.org/10.1093/noajnl/vdab071.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351243/
http://dx.doi.org/10.1093/noajnl/vdab071.040

Ejemplares similares